Year: 2025

LOS ANGELES, March 12, 2025 (GLOBE NEWSWIRE) — Big Screen Entertainment Group (OTC: BSEG) is making a bold expansion into the booming beauty industry—an ever-growing global market projected to exceed $700 billion by 2028. The Los Angeles-based film and television company has completed filming on the pilot episode of a beauty-focused TV show, seamlessly integrating a new line of cutting-edge beauty products backed by top industry experts. This venture marks a strategic expansion for Big Screen, leveraging its entertainment expertise to enter one of the most profitable consumer sectors. While the name of the series and details of the product line remain confidential for now, audiences can expect a blend of Hollywood glamour and transformative beauty experiences featuring a lineup of well-known faces. Among them is celebrated actress Kelli...

ATHENS, Greece, March 12, 2025 (GLOBE NEWSWIRE) — Diana Shipping Inc. (NYSE: DSX), (the “Company”), a global shipping company specializing in the ownership and bareboat charter-in of dry bulk vessels, today announced that through a separate wholly-owned subsidiary, it has entered into a time charter contract with Cargill International SA, Geneva, for one of its Kamsarmax dry bulk vessels, the m/v Medusa. The gross charter rate is US$13,000 per day, minus a 4.75% commission paid to third parties, for a period until minimum May 15, 2026 up to maximum July 15, 2026. The charter is expected to commence on March 15, 2025. The “Medusa” is an 82,194 dwt Kamsarmax dry bulk vessel built in 2010. The employment of “Medusa” is anticipated to generate approximately US$5.46 million of gross revenue for the minimum scheduled period of the time...

GAITHERSBURG, Md., March 12, 2025 (GLOBE NEWSWIRE) — Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma”), a discovery and development stage specialty pharmaceutical company focused on improving outcomes for cancer patients treated with radiation therapy (RT), announced today the pricing of an underwritten public offering of 19,166,667 shares of its common stock (or pre-funded warrants to purchase common stock in lieu thereof) at a public offering price of $0.30 per share (the “Offering”). The aggregate gross proceeds to Shuttle Pharma from the Offering are expected to be approximately $5.75 million, before deducting underwriting discounts and commissions and other estimated offering expenses payable by Shuttle Pharma. The Offering is expected to close on March 13, 2025, subject to the satisfaction of customary...

PITTSBURGH, March 12, 2025 (GLOBE NEWSWIRE) — Coherent Corp. (NYSE: COHR), the leader in advanced laser technology, is proud to announce the launch of its groundbreaking 793nm pump laser diode, setting a new industry standard with an impressive 28W of reliable power and 97% polarization purity. This innovative product offers unmatched performance and cost-efficiency, unlocking new possibilities for applications in the rapidly growing Thulium fiber laser market. A Game-Changer in Thulium Fiber Laser TechnologyThe increasing adoption of Thulium fiber lasers in medical applications has transformed patient care, offering a safer, more comfortable treatment experience with faster recovery times. With the market for Thulium fiber lasers projected to grow significantly, the new 793nm chip from Coherent is poised to meet the growing demand...

Encouraging Safety Profile Supports Progression Toward First Dual-Administration of Selective A2A and A2B Antagonists in Patients DOVER, Del., March 12, 2025 (GLOBE NEWSWIRE) — Portage Biotech Inc. (“Portage” or the “Company”) (NASDAQ: PRTG), a clinical-stage immuno-oncology company with a portfolio of innovative therapeutics, today announced the resumption of patient enrollment in the fourth and final cohort of the dose escalation stage for PORT-6, a highly selective A2A antagonist, within its ADPORT-601 Phase 1b clinical trial. Portage had previously paused this trial due to funding concerns; this resumption of the trial underscores the encouraging findings observed in earlier cohorts. After the completion of the PORT-6 arm of the ADPORT-601 study, Portage will evaluate the continuation of the study into its PORT-7 (potent and...

GAITHERSBURG, Md. and BASEL, Switzerland, March 12, 2025 (GLOBE NEWSWIRE) — Emergent BioSolutions Inc. (NYSE: EBS), a leading public health company that delivers protective and life-saving solutions to communities across the world, and Rocketvax Ltd, one of Switzerland’s next-generation vaccine companies and a member of the Swiss Rockets Ltd family of companies, today announced entry into an agreement for Emergent’s strategic financial investment into Swiss Rockets Ltd, the parent company of Rocketvax Ltd, to support research, infrastructure development, and the expansion of Swiss Rockets’ innovative biotechnology portfolio. This endeavor underscores Emergent’s commitment to supporting Swiss Rockets’ broader mission of pioneering breakthrough medical technologies. In addition to the investment, the parties intend to form a strategic...

WILMINGTON, Del., March 12, 2025 (GLOBE NEWSWIRE) — Brand Engagement Network Inc. (BEN) (NASDAQ: BNAI), an innovator in AI-driven customer engagement solutions, has announced its support for California Assembly Member Carl DeMaio’s proposed AI data privacy legislation. This bill, which aims to secure the privacy of California residents, would require businesses to obtain explicit consent before sharing or storing user data outside the United States. As AI adoption accelerates across industries, the need for robust data protection has never been more critical. BEN recognizes the importance of securing user data and supports DeMaio’s initiative as a vital step in advancing privacy protections in the AI space. “Data privacy is a fundamental right, and it is crucial that we hold ourselves accountable in developing AI technologies,”...